All Work

Jon C. Ogg

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.

Jon C. Ogg · 7 years ago

A Radical Turn for the Sprint and T-Mobile Merger

While most investors had been led to believe that the proposed acquisition of Sprint by T-Mobile would be blocked, the FCC has indicated a more favorable position for the proposed merger.

Jon C. Ogg · 7 years ago

Consumer Sentiment Rises Strongly Ahead of Tariff Fears

If you listened to certain factions of mainstream media, the tariffs against China might have you fearing that a full-blown recession is coming on the back of an all-out trade war. Apparently, consumer sentiment…

Jon C. Ogg · 7 years ago